Close
ACHEMA MIDDLE EAST 2026

Japan, Norway Partner To Strengthen Global Pandemic Response

AI Summary

The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership between both organisations as they look forward to speeding up global preparedness as well as response to any future pandemics.

Both CEPI and SCARDA have shared missions when it comes to funding the development of vaccines against diseases that are infectious and hence this new collaboration is going to assist the organisations in sharing expertise, experience, as well as knowledge and partner on the work areas that help contribute to the goals when it comes to both organisations.

It is well to be noted that by way of both partnerships, both organisations will be able to share information and insights on vaccine development, health security, manufacturing, and other themes that concern the preparedness of pandemics and epidemics. The partners will go ahead with a collaboration in terms of vaccine development in the case of priority pathogens as well as priority virus families of mutual interest, enabling them to select as well as focus when it comes to c complementary projects as well as investments sans duplicating the effort or even the resources.

CEPI and SCARDA will also look to coordinate on functions that go on to support the 100-Days mission, which happens to be embraced by the G7 as well as the G20 and which looks to speed up the time taken to create safe, effective, and accessible vaccines when it comes to emerging diseases having pandemic potential to 100 days.

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES